abstract |
The present invention relates to inhibitors of transient receptor potential channel 6 (TRPC6) protein activity. The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound according to the invention, a process for producing the compounds according to the invention and associated therapeutic uses. |